Stay updated on Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedA sitewide NIH banner announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.4%

- Check35 days agoChange DetectedThe website footer revision changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry, v3.7.0, has been added to the study record history and the old entry, v3.6.6, has been removed, updating the history to reflect the latest revision.SummaryDifference0.1%

Stay in the know with updates to Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.